http://www.mmm-online.com/restructure/topic/12990/ Articles tagged with Restructure from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Days after announcing a sharp downsizing, the patent expiry-plagued company said it will eliminate an additional 2,300 jobs, raising the tally of cuts to more than 5,000 through 2016. http://www.mmm-online.com/more-pink-slips-at-astrazeneca/article/285381/ Thu, 21 Mar 2013 15:13:01 GMT Days after announcing a sharp downsizing, the patent expiry-plagued company said it will eliminate an additional 2,300 jobs, raising the tally of cuts to more than 5,000 through 2016. MMM Former Pfizer chieftain Hank McKinnell is taking the reins at stock scandal-plagued Optimer—perchance to sell it to Pfizer? http://www.mmm-online.com/ex-pfizer-chief-takes-over-at-troubled-optimer/article/282245/ Thu, 28 Feb 2013 05:23:45 GMT Former Pfizer chieftain Hank McKinnell is taking the reins at stock scandal-plagued Optimer—perchance to sell it to Pfizer? MMM The latest executive change has a touch of deja-vu: Novartis vet Jorg Reinhardt is returning from a stint at Bayer.The company also said it expects 2013 sales to be flat, but sees growth in 2014 and 2015. http://www.mmm-online.com/novartis-shakes-up-c-suite-as-sales-slide-3/article/277245/ Wed, 23 Jan 2013 17:31:10 GMT The latest executive change has a touch of deja-vu: Novartis vet Jorg Reinhardt is returning from a stint at Bayer.The company also said it expects 2013 sales to be flat, but sees growth in 2014 and 2015. MMM Endo is restructuring, bringing its four operating units under the same corporate roof and rebranding to reflect its diversification out of its origins in pain and urology drugs. http://www.mmm-online.com/endo-rebrands-to-move-beyond-roots-in-pain-drugs/article/230514/ Fri, 02 Mar 2012 19:14:01 GMT Endo is restructuring, bringing its four operating units under the same corporate roof and rebranding to reflect its diversification out of its origins in pain and urology drugs. MMM Sanofi is girding itself for an ugly year, forecasting a 12%-15% drop in business earnings per share for 2012 as the company absorbs the loss of patent exclusivity on a stable of drugs that brought in more than €4 billion last year. http://www.mmm-online.com/sanofi-braces-for-patent-cliff-impact/article/227180/ Thu, 09 Feb 2012 21:51:21 GMT Sanofi is girding itself for an ugly year, forecasting a 12%-15% drop in business earnings per share for 2012 as the company absorbs the loss of patent exclusivity on a stable of drugs that brought in more than €4 billion last year. MMM Abbott said today it will separate into two publicly traded companies, one its $18-billion pharma unit and the other its $22-billion diversified medical products business. http://www.mmm-online.com/abbott-to-split-off-branded-pharma-unit-pursue-specialty-drug-focus/article/214785/ Wed, 19 Oct 2011 20:19:47 GMT Abbott said today it will separate into two publicly traded companies, one its $18-billion pharma unit and the other its $22-billion diversified medical products business. MMM Digitas Health and Razorfish Health are undergoing an organizational restructure in which the two Publicis-owned siblings will share two newly appointed co-presidents, launch a single global leadership team and develop a variety of centers of excellence. http://www.mmm-online.com/digitas-health-razorfish-health-to-share-new-leadership-global-team-in-efficiency-driven-reorg/article/205975/ Thu, 23 Jun 2011 17:14:16 GMT Digitas Health and Razorfish Health are undergoing an organizational restructure in which the two Publicis-owned siblings will share two newly appointed co-presidents, launch a single global leadership team and develop a variety of centers of excellence. MMM